<html>
  <div class="bg-white p-4 rounded shadow-md">
    <h4 class="text-lg font-bold mb-2">Safety Information</h4>
    <p class="text-gray-600 mb-4">As a healthcare professional, it's essential to understand the safety profile of Oncozen, a cost-effective innovation in oncology treatment.</p>
    <ul class="list-none mb-4">
      <li class="flex items-start mb-2">
        <svg class="w-4 h-4 text-green-600 mr-2" fill="none" stroke="currentColor" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5-3l2 2 4-4"></path></svg>
        <span class="text-gray-600">Oncozen has been shown to have a favorable safety profile in clinical trials, with a low incidence of severe adverse events.</span>
      </li>
      <li class="flex items-start mb-2">
        <svg class="w-4 h-4 text-green-600 mr-2" fill="none" stroke="currentColor" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5-3l2 2 4-4"></path></svg>
        <span class="text-gray-600">The most common adverse events reported were mild to moderate and reversible, with no unexpected safety signals identified.</span>
      </li>
    </ul>
    <p class="text-gray-600 mb-4">For more information on the safety profile of Oncozen, please refer to the full prescribing information or contact our medical information team.</p>
  </div>
</html>